Il tuo browser è obsoleto

Con un browser aggiornato, l'esperienza di navigazione sul sito Web di Medtronic sarà migliore. Aggiorna il mio browser adesso.

×

Skip to main content

Professionisti del settore sanitario

Bioresorbable Nasal Packing Products

  • MeroGel Injectable Bioresorbable Nasal Packing from Medtronic

MeroGel Injectable

MeroGel Injectable nasal packing may help prevent adhesions and middle turbinate lateralization, a common cause of FESS failure.1-3

A Flexible Catheter for Hard-to-Reach Areas

MeroGel Nasal Packing Results in Fewer Adhesions

MeroGel® Injectable nasal packing is a bioresorbable, space-occupying gel stent used after functional endoscopic sinus surgery (FESS) or nasal trauma. It's composed of cross-linked polymers of hyaluronic acid and administered with a flexible catheter for easier access to nasal cavities.

During the important postoperative period, MeroGel Injectable nasal packing is intended to:

  • Separate and prevent adhesions between mucosal surfaces
  • Help control minimal bleeding following surgery or nasal trauma
  • Act as an adjunct to aid in the natural healing process
  • Eliminate the need for painful nasal packing removal for patients

Hyaluronic Acid: Fewer Adhesions, Reduced Healing Time

Our bioresorbable nasal packing products use hyaluronic acid, a linear polysaccharide and naturally occurring constituent of the extracellular matrix.

Hyaluronic acid helps keep the surgical site moist, reduce adhesions, and decrease healing time.4 Esterified hyaluronic acid, or HYAFF®, is a patented formula that is used in our MeroGel and MeroPack® nasal packing products.

The Right Nasal Packing for Your Patient

We offer several bioresorbable nasal packing products to suit the needs of your patients, including MeroGel packing and MeroPack. You can also view traditional nasal packing in our ENT Product Catalog.

 

HYAFF® is a registered trademark of Fidia Advanced Biopolymers.

References

1

Musy PY, Kountakis SE. Anatomic findings in patients undergoing revision endoscopic sinus surgery. Am J Otolaryngol. 2004; 25(6):418-422.

2

Ramadan HH. Surgical causes of failure in endoscopic sinus surgery. Laryngoscope. 1999; 109:27-29.

3

Kuhn FA, Citardi MJ. Advances in postoperative care following endoscopic sinus surgery. Otolaryngol Clin North Am. 1997; 30(3):479-490.

4

Berlucchi M, Castelnuovo P, Vincenzi A, Morra B, Pasquini E. Endoscopic outcomes of resorbable nasal packing after functional endoscopic sinus surgery: a multicenter prospective randomized controlled study. Eur Arch Otorhinolaryngol. 2009; 266(6): 839-845.

Medtronic Italia S.p.A. Società a socio unico soggetta ad attività di direzione e coordinamento da parte di Medtronic PLC.
Cap. soc. € 1.200.487,00 - Codice fiscale, partita IVA e numero di iscrizione al Registro delle Imprese di Milano-Monza-Brianza-Lodi 09238800156 – REA MI – 1275682. Sede Legale e Uffici Via Varesina, 162 Edificio Raimondi - 20156 Milano.